GXYLT1
Glucoside xylosyltransferase 1
Also known as: FLJ43151, GLT8D3, GXLT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4G148
- Gene
- GXYLT1
- Ensembl
- ENSG00000151233
- Chromosome
- 12
- Canonical length
- 440 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum,Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
GXYLT1 is a xylosyltransferase (EC 2.4.2.-) that adds the first xylose to O-glucose-modified residues in the epidermal growth factor (EGF; MIM 131530) repeats of proteins such as NOTCH1 (MIM 190198) (Sethi et al., 2010 [PubMed 19940119]).[supplied by OMIM, Mar 2010]
Canonical amino-acid sequenceUniProt
440 residues, UniProt reviewed canonical sequence.
>Q4G148|GXYLT1
1 MRRYLRVVVL CVACGFCSLL YAFSQLAVSL EEGTGGGGGK PQAAVASWLA GGGRGAVRGA
61 GVAGPAAHPG VSDRCKDFSL CYWNPYWMLP SDVCGMNCFW EAAFRYSLKI QPVEKMHLAV
121 VACGERLEET MTMLKSAIIF SIKPLQFHIF AEDQLHHSFK GRLDNWSFLQ TFNYTLYPIT
181 FPSENAAEWK KLFKPCASQR LFLPLILKEV DSLLYVDTDI LFLRPVDDIW SLLKKFNSTQ
241 IAAMAPEHEE PRIGWYNRFA RHPYYGKTGV NSGVMLMNMT RMRRKYFKND MTTVRLQWGD
301 ILMPLLKKYK LNITWGDQDL LNIVFFHNPE SLFVFPCQWN YRPDHCIYGS NCQEAEEGGI
361 FILHGNRGVY HDDKQPAFRA VYEALRNCSF EDDNIRSLLK PLELELQKTV HTYCGKIYKI
421 FIKQLAKSVR DRYARSPKEKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GXYLT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- liver: 12 nTPM
- placenta: 10 nTPM
- testis: 8.9 nTPM
- thyroid gland: 8.3 nTPM
- bone marrow: 7.1 nTPM
- thymus: 6.4 nTPM
Single-cell type
- sertoli cells: 95 nCPM
- cytotrophoblasts: 78 nCPM
- rod photoreceptor cells: 75 nCPM
- neutrophil progenitors: 75 nCPM
- syncytiotrophoblasts: 73 nCPM
- gonadotrophs: 69 nCPM
Immune cell
- eosinophil: 1.8 nTPM
- non-classical monocyte: 1.5 nTPM
- intermediate monocyte: 1.2 nTPM
- myeloid DC: 1 nTPM
- NK-cell: 0.9 nTPM
- T-reg: 0.7 nTPM
Brain region
- hypothalamus: 14 nTPM
- spinal cord: 12 nTPM
- medulla oblongata: 12 nTPM
- white matter: 11 nTPM
- midbrain: 11 nTPM
- thalamus: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 0.36
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity
- UDP-xylosyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GXYLT1 as an antibody target. Whether an autoantibody or antibody against GXYLT1 could matter depends on whether native GXYLT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GXYLT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GXYLT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...